Unknown

Dataset Information

0

Molecular heterogeneity of gelatin-binding proteins from human seminal plasma.


ABSTRACT: Defining the molecular characteristics of seminal plasma proteins is essential for understanding their function in physiological and pathological conditions. Starting from the predicted importance of human seminal plasma gelatin-binding proteins, comprising fibronectin (FN) and FN-related molecules, for male fertility, this study aims at gaining insight into their immuno-glycobiochemical properties. Human seminal plasma from subjects with normal semen parameters were separated on a gelatin-Sepharose column and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting using antibodies against distinct FN forms. Heterogeneity of the isolated molecular species was examined by protein chip arrays combined with surface-enhanced laser desorption/ionization time of flight mass spectrometry, on normal, metal and hydrophobic surfaces. Carbohydrate composition was investigated using mannose-, fucose- and sialic acid-specific plant lectins and galectin-1. The results obtained indicated a pattern of isolated proteins corresponding to that of known FN fragments, as confirmed by immunoreactivity. Among them heparin-binding ability was preferentially associated with low molecular mass species. As for posttranslational modifications, phosphorylation and glycosylation of distinct fragments were revealed. Lectin binding to fragments containing the gelatin-binding domain, particularly with Ricinus communis agglutinin I, was stronger than to fragments containing the cell-binding site of FN. A low level of sialylation and distinctive concanavalin A- and Lens culinaris agglutinin-reactive species were also observed. Galectin-1 did not interact with the isolated preparation. Resolving the molecular heterogeneity of normal human seminal plasma FN and gaining initial insight into possible similarities/differences with known FN molecular species may be considered a prerequisite step preceding challenging the clinical usefulness of these molecular properties.

SUBMITTER: Kosanovic MM 

PROVIDER: S-EPMC3739261 | biostudies-other | 2010 May

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC3174039 | biostudies-literature
| S-EPMC5061705 | biostudies-literature
| S-EPMC1145028 | biostudies-other
| S-EPMC1137585 | biostudies-other
| S-EPMC8457112 | biostudies-literature
| S-EPMC7933687 | biostudies-literature
| S-EPMC1135940 | biostudies-other
| S-EPMC1137565 | biostudies-other
| S-EPMC5639412 | biostudies-literature
2016-06-28 | E-GEOD-78131 | biostudies-arrayexpress